Navigation Links
Novel Vaccine Approach Offers Hope in Fight Against HIV
Date:5/17/2009

--Gene Transfer Technology May Lead to an HIV Vaccine--

PHILADELPHIA, May 17 /PRNewswire-USNewswire/ -- A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers. By using gene transfer technology that produces molecules that block infection, the scientists protected monkeys from infection by a virus closely related to HIV -- the simian immunodeficiency virus, or SIV -- that causes AIDS in rhesus monkeys.

"We used a leapfrog strategy, bypassing the natural immune system response that was the target of all previous HIV and SIV vaccine candidates," said study leader Philip R. Johnson, M.D., chief scientific officer at The Children's Hospital of Philadelphia. Johnson developed the novel approach over a ten-year period, collaborating with K. Reed Clark, Ph.D., a molecular virologist at Nationwide Children's Hospital in Columbus, Ohio.

The study appeared today in the online version of Nature Medicine.

Johnson cautioned that many hurdles remain before the technique used in this animal study might be translated into an HIV vaccine for humans. If the technique leads to an effective HIV vaccine, such a vaccine may be years away from realization.

Most attempts at developing an HIV vaccine have used substances aimed at stimulating the body's immune system to produce antibodies or killer cells that would eliminate the virus before or after it infected cells in the body. However, clinical trials have been disappointing. HIV vaccines have not elicited protective immune responses, just as the body fails on its own to produce an effective response against HIV during natural HIV infection.

The approach taken in the current study was divided into two phases. In the first phase, the research team created antibody-like proteins (call
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials
2. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
3. VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
4. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
7. Worldwide Sensation: "A"- Implant Novelty From Austria
8. Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology
9. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
10. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
11. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 About 8 ... legs due to buildup of fatty plaque in the ... the aging patient population and in incidences of diabetes ... offers its Lower Extremity Arterial RevascularizatioN (LEARN) ... Endovascular specialists and interested residents and fellows will ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Global Orthopedic ... http://www.reportlinker.com/p02316671/Global-Orthopedic-Soft-Tissue-Repair-Devices-Market-2014-2018.html About ... are the mass of cells that connect, support, ... orthopedic soft tissues such as tendons, ligaments, cartilage, ...
(Date:8/27/2014)... BURLINGTON, Mass. , Aug. 27, 2014 /PRNewswire/ ... six different specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, ... of clinical trials that a biosimilar has been ... which biosimilar product they choose to prescribe. ... Advisory Service report entitled Acceptance of ...
Breaking Medicine Technology:LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2
... SOUTH EASTON, Mass., July 1 Pressure,BioSciences, Inc. ... scientists,from the New York University ("NYU") School of ... on advances they made in the,areas of breast ... The results were generated in studies using PBI,s ...
... Agennix Incorporated today announced,the publication of final results ... in patients who had failed previous treatment for,advanced ... the study,which were reported in the July 1 ... demonstrate that talactoferrin is active in RCC, has ...
Cached Medicine Technology:Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies 2Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 2Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 4Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 5
(Date:8/27/2014)... 27, 2014 China’s regulatory framework ... of dramatic changes. The country’s new leaders have ... of medical equipment are far from being alongside ... past 30 years. Chinese state council issued the ... Medical Devices” to try to completely change such ...
(Date:8/27/2014)... Toronto, Ontario (PRWEB) August 27, 2014 When ... getting a call from his mother; one that he credits ... ever received. His mom had news that she could set ... camp supporting people with disabilities. Jagger took that job, and ... the disabled. Throughout these past two decades, he also worked ...
(Date:8/27/2014)... Aug. 27, 2014 (HealthDay News) -- A new study ... effective treatment for seniors with sleep apnea. CPAP ... sleep apnea, a condition in which the airway relaxes ... sleep that leads to daytime drowsiness. ... of air through a patient,s nose via a mask ...
(Date:8/27/2014)... parents shapes many aspects of our lives. But in ... is set during development, but can be altered by ... of our parents and grandparents. , The epigenome consists ... that determine whether genes are expressed or silenced. , ... health, but also that it may be possible to ...
(Date:8/27/2014)... Tejal K. Gandhi, MD, MPH, CPPS, president ... the NPSF Lucian Leape Institute, is among the 100 Most ... of Modern Healthcare magazine. Also on the list are NPSF ... MBA; NPSF Lucian Leape Institute members Carolyn Clancy, MD; ... member of both the Institute and the NPSF Board of ...
Breaking Medicine News(10 mins):Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 2Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 3Health News:Scientists map the 'editing marks' on fly, worm, human genomes 4Health News:NPSF President Among 100 Most Influential in Health Care 2Health News:NPSF President Among 100 Most Influential in Health Care 3
... Oct. 27, 2011 Are children suffering needlessly after ... believe so. An operation can be one of ... a UCI study, many of them experience unnecessary postsurgical ... is well understood and treated in adults but has ...
... FINDINGS: Whitehead Institute scientists have determined that master transcription ... In this way, signaling pathways are targeted to genes ... tailor gene expression to control cell state, growth, differentiation, ... pathways operate properly, a cell receives instructions from its ...
... -- One of the things that makes inhalational anthrax so ... number of inhaled anthrax spores can turn into a lethal ... she has something worse than the flu and seeks treatment, ... be no help against the spreading bacteria and the potent ...
... and financially during adolescence and early adulthood takes its toll ... in middle aged men and women, irrespective of how tough ... E. Gustafsson from Ume University in Sweden and colleagues, experience ... into adulthood is linked to a rise in disease risk ...
... presence of a predator causes enough stress to kill a ... prey to eat it, say biologists at the University of ... eaten is an important topic in ecology, and we,ve learned ... prey interactions," says Professor Locke Rowe, chair of the Department ...
... The New England Regional Spinal Cord Injury Center at ... Spinal Cord Injury Model System (SCIMS) by the National ... are awarded in five-year cycles by the NIDRR through ... NIDRR supports innovative research in the delivery, demonstration ...
Cached Medicine News:Health News:How major signaling pathways are wired to our genome gives new insight into disease processes 2Health News:How major signaling pathways are wired to our genome gives new insight into disease processes 3Health News:Natural killer cells could be key to anthrax defense 2Health News:Hard times during adolescence point to health problems later in life 2Health News:Insects are scared to death of fish 2
... Medical Delta valve is designed to ... and maintain intraventricular pressure (IVP) within ... patient position. The normally closed Delta ... positive ventricular pressure. Working with the ...
... is an adjustable flow control valve in ... can be changed non-invasively by the caregiver. ... cerebrospinal fluid (CSF) and maintain intraventricular pressure ... of patient position. The normally closed Delta ...
...
... try Cadwell paired disc electrodes. They combine ... contacts are 10 mm (0.4 in) in ... steel with a locator pin on the ... and available in twisted pairs. Shielded paired ...
Medicine Products: